157 related articles for article (PubMed ID: 2754697)
1. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
Stefanska B; Dzieduszycka M; Martelli S; Borowski E
J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.
Dzieduszycka M; Martelli S; Tarasiuk J; Paradziej-Lukowicz J; Borowski E
J Med Chem; 1991 Feb; 34(2):541-6. PubMed ID: 1995874
[TBL] [Abstract][Full Text] [Related]
5. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones.
Krapcho AP; Petry ME; Hacker MP
J Med Chem; 1990 Sep; 33(9):2651-5. PubMed ID: 2391703
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones.
Krapcho AP; Landi JJ; Hacker MP; McCormack JJ
J Med Chem; 1985 Aug; 28(8):1124-6. PubMed ID: 4020835
[TBL] [Abstract][Full Text] [Related]
7. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
Murdock KC; Child RG; Fabio PF; Angier RB; Wallace RE; Durr FE; Citarella RV
J Med Chem; 1979 Sep; 22(9):1024-30. PubMed ID: 490545
[TBL] [Abstract][Full Text] [Related]
9. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
10. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
[TBL] [Abstract][Full Text] [Related]
11. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
Cholody WM; Martelli S; Konopa J
J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agents. 2. Bisguanylhydrazones of anthracene-9,10-dicarboxaldehydes.
Murdock KC; Child RG; Lin Y; Warren JD; Fabio PF; Lee VJ; Izzo PT; Lang SA; Angier RB; Citarella RV; Wallace RE; Durr FE
J Med Chem; 1982 May; 25(5):505-18. PubMed ID: 6806475
[TBL] [Abstract][Full Text] [Related]
13. New antitumor agents containing the anthracene nucleus.
Wunz TP; Dorr RT; Alberts DS; Tunget CL; Einspahr J; Milton S; Remers WA
J Med Chem; 1987 Aug; 30(8):1313-21. PubMed ID: 2441053
[TBL] [Abstract][Full Text] [Related]
14. 1,4-disubstituted anthracene antitumor agents.
Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
Dumont P; Fuks R; Atassi G; Hanocq M
J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
[No Abstract] [Full Text] [Related]
16. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
[TBL] [Abstract][Full Text] [Related]
18. 5-(2-Oxo-3-indolinylidene)thiazolidine-2,4-dione-1,3-di-Mannich base derivatives: synthesis and evaluation for antileukemic activity.
Eshba NH; Salama HM
Pharmazie; 1985 May; 40(5):320-2. PubMed ID: 4034634
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
Anderson WK; Bhattacharjee D; Houston DM
J Med Chem; 1989 Jan; 32(1):119-27. PubMed ID: 2909723
[TBL] [Abstract][Full Text] [Related]
20. 5-[(Aminoalkyl)amino]imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity.
Cholody WM; Martelli S; Paradziej-Lukowicz J; Konopa J
J Med Chem; 1990 Jan; 33(1):49-52. PubMed ID: 2296035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
